13/11/2024  13:24:26 Var. -1.20 Volume Denaro13:24:27 Lettera13:24:27 Capitalizzazione di mercato Dividend Y. Rapporto P/E
215.40CHF -0.55% 15,669
Fatturato: 3.38 mill.
215.00Quantità in denaro: 62 215.60Quantità in lettera: 54 2.75 bill.CHF 0.70% 20.83

Descrizione business

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Achim von Leoprechting
Consiglio di amministrazione
Tania Micki, Andreas Wilhelm, Dr. Wael Yared, Erik Norström, Ingrid Pürgstaller, Ralf Griebel, Ulrich Kanter, Mukta Acharya
Consiglio di sorveglianza
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Myra Eskes, Matthias Gillner, Monica Manotas
 

Dati aziendali

Name: Tecan Group AG
Indirizzo: Seestrasse 103,CH-8708 Männedorf
Telefono: +41-44-922-8111
Fax: +41-44-922-8112
E-mail: info@tecan.com
Internet: www.tecan.com
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 61.50%
Data dell'IPO: -

Rapporti con gli investitori

Name: Martin Brändle
IR telefono: +41-44-922-8430
IR Fax: +41-44-922-8889
IR e-mail: investor@tecan.com

Principali azionisti

Altri
 
55.70%
Chase Nominees Ltd.
 
12.20%
UBS Fund Management AG
 
5.10%
APG Algemene Pensioen Groep N.V
 
4.50%
BlackRock Inc.
 
4.50%
FIL Limited, Pembroke
 
3.00%
Candriam Luxembourg
 
3.00%
Swisscanto Fondsleitung AG
 
3.00%
Credit Suisse Funds AG
 
3.00%
Altri
 
6.00%